Homocysteine levels and the metabolic syndrome in a Mediterranean population: A case-control study

Clinical Hemorheology and Microcirculation

Volumn 47, Issue 1, 2011, Pages 59-66

  Vayá, Amparo ^a   Carmona, Pilar ^a   Badia, Natalia ^a   Pérez, Rafael ^b   Mijares, Antonio Hernandez ^c   Corella, Dolores ^d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Transfusion Center of the Valencian Community   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYANOCOBALAMIN; FIBRINOGEN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEUTROPHIL COUNT; PLASMA VISCOSITY; SOUTHERN EUROPE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 79951845512     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1366     Document Type: Article

References (34)

1. F. Abbasi, F. Facchini, M.H. Humphreys and G.M. Reaven, Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal, Atherosclerosis 146 (1999), 175-178. (Pubitemid 29371876)
2. K.G. Alberti, P. Zimmet and J. Shaw, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome a new worldwide definition, Lancet 366 (2005), 1059-1062. (Pubitemid 41338752)
3. N.M. Al-Daghri, Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population, Saudi Med J 28 (2007), 339-346. (Pubitemid 46613381)
4. O.K. Baskurt, M. Boynard, G.C. Cokelet, P. Connes, B.M. Cooke, S. Forconi, F. Liao, M.R. Hardeman, F. Jung, H.J. Meiselman, G. Nash, N. Nemeth, B. Neu, B. Sandhagen, S. Shin, G. Thurston and J.L. Wautier, International expert panel for standardization of hemorheological methods. New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97.
5. A. Becker,Y.M. Smulders, C. van Guldener and C.D. Stehouwer, Epidemiology of homocysteine as a risk factor in diabetes, Metab Syndr Relat Disord 1 (2003), 105-120.
6. J. Björck, M. Hellgren, L. Råstam and U. Lindblad, Associations between serum insulin and homocysteine in a Swedish population - a potential link between the metabolic syndrome and hyperhomocysteinemia: The Skaraborg project, Metabolism 55 (2006), 1007-1013.
7. N. Budak, C. Yazici, A. Oztürk, F. Bayram, M.M. Maziciolu and S. Kurtoglu, Is plasma homocysteine level associated with metabolic syndrome components in adolescents? Metab Syndr Relat Disord 7 (2009), 357-362.
8. M.A. Cornier, D. Dabelea, T.L. Hernández, R.C. Lindstrom, A.J. Steig, N.R. Stob, et al., The metabolic syndrome, Endocr Rev 29 (2008), 777-822.
9. J.W. Eikelboom, E. Lonn, J. Genest, G. Hankey and S. Yusuf, Homocysteine and cardiovascular disease: A critical review of the epidemiologic evidence, Ann Intenn Med 131 (1999), 363-375. (Pubitemid 29424631)
10. M. El Oudi, Z. Aouni, H. Quertani, C. Mazigh and S. Machghoul, Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics, Vasc Health Risk Manag 6 (2010), 327-332.
11. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001), 2486-2497.
12. V.A. Fonseca, L.M. Fink and P.A. Kern, Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects, Atherosclerosis 167 (2003), 105-109. (Pubitemid 36255641)
13. A.S. Gami, B.J. Witt, D.E. Howard, P.J. Erwin, L.A. Gami, V.K. Somers, et al., Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies, J Am Coll Cardiol 49 (2007), 403-414. (Pubitemid 46135879)
14. J.M. Garcin, S. Cremades, C. Garcia-Hejl, L. Bordier,O. Dupuy,H. Mayaudon and B. Bauduceau, Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome? Metab Syndr Relat Disord 4 (2006), 185-195. (Pubitemid 44613399)
15. R. Gillum, Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: The third national health and nutrition examination survey, Nutr J 5 (2003), 2-6.
16. I.F. Godsland, J.R. Rosankiewicz, A.J. Proudler and D.G. Johnston, Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men, J Clin Endocrinol Metab 86 (2001), 719-723. (Pubitemid 32207486)
17. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, et al., Diagnosis and management of the metabolic syndrome: An American heart association/national heart, lung, and blood institute scientific statement: Executive summary, Circulation 112 (2005), 2735-2752. (Pubitemid 41532612)
18. D. Gu, K. Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, et al., InterASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in China, Lancet 365 (2005), 1398-1405. (Pubitemid 40523734)
19. A. Guven, F. Inanc, M. Kilinc and H. Ekerbicer, Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome, Heart Vessels 20 (2005), 290-295. (Pubitemid 43013220)
20. G.R. Hajer,Y. van der Graaf, J.K. Olijhoek, M.C.Verhaar and F.L.Visseren, SMART Study Group, Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome, Heart 93 (2007), 216-220. (Pubitemid 46180299)
21. G.J. Hankey, J.W. Eikelboom,W.K. Ho and F.M. van Bockxmeer, Clinical usefulness of plasma homocysteine in vascular disease, Med J Aust 181 (2004), 314-318. (Pubitemid 39302714)
22. F. Jung, H.G. Roggenkamp, R. Scheider and H. Kiesewetter, Das kapillarschlauch-plasmaviskosimeter ein neues messgerät zur quantifizierung der blutplasmaviskosität, Biomed Technik 28 (1983), 249-252.
23. B. Kirilmaz, F. Asgun, E. Alioglu, E. Ercan, I. Tengiz, U. Turk, S. Saygi and F. Ozerkan, High inflammatory activity related to the number of metabolic syndrome components, J Clin Hypertens (Greenwich) 2 (2010), 136-144.
24. J.B. Meigs, P.F. Jacques, J. Selhub, D.E. Singer, D.M. Nathan, N. Rifai, R.B. D'Agostino Sr. and P.W.Wilson, Framingham Offspring Study, Fasting plasma homocysteine levels in the insulin resistance syndrome: The Framingham offspring study, Diabetes Care 24 (2001), 1403-1410. (Pubitemid 33716428)
25. I. Nabipour, A. Ebrahimi, S.M. Jafari, K. Vahdat, M. Assadi, A. Movahed, F. Moradhaseli, N. Obeidi and Z. Sanjdideh, The metabolic syndrome is not associated with homocysteinemia: The Persian gulf healthy heart study, J Endocrinol Invest 32 (2009), 406-410.
26. L.H. Opie, Metabolic syndrome, Circulation 115 (2007), 32-35.
27. Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethhon and S.B. Heymsfield, The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994, Arch Intern Med 163 (2003), 427-436. (Pubitemid 36241019)
28. E.J. Rhee, S.T. Hwang, W.Y. Lee, J.H. Yoon, B.J. Kim, B.S. Kim, J.H. Kang, M.H. Lee, J.R. Park and K.C. Sung, Relationship between metabolic syndrome categorized by newly recommended by international diabetes federation criteria with plasma homocysteine concentration, Endocr J 54 (2007), 995-1002.
29. G. Schillaci, M. Pirro, G. Vaudo, F. Gemelli, S. Marchesi, C. Porcellati, et al., Prognostic value of the metabolic syndrome in essential hypertension, J Am Coll Cardiol 43 (2004), 1817-1822. (Pubitemid 38622521)
30. A. Scuteri, S.S. Najjar, C.H. Morrell and E.G. Lakatta, Cardiovascular Health Study. The metabolic syndrome in older individuals: Prevalence and prediction of cardiovascular events: The cardiovascular health study, Diabetes Care 28 (2005), 882-887. (Pubitemid 40434490)
31. L.M. Steffen, M. Cushman, J.M. Peacock, S.R. Heckbert, D.R. Jacobs Jr.,W.D. Rosamond, et al., Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE), J Thromb Haemost 7 (2009), 746-751.
32. F. Tanrikulu-Kiliç, S. Bekpinar, Y. Unlüçerçi and Y. Orhan, Insulin resistance is not related to plasma homocysteine concentration in healthy premenapausal women, Physiol Res 55 (2006), 285-290.
33. A. Vayá, I. Gómez, Y. Mira, F. Ferrando and D. Corella, Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects, Thromb Haemost 99 (2008), 1132-1134. (Pubitemid 351810503)
34. M. Yakub, M.P. Iqbal and R. Iqbal, Dietary patterns are associated with hyperhomocysteinemia in an urban pakistani population, J Nutr 140 (2010), 1261-1266.